Research Article

Artificial Intelligence and Systemic Isotretinoin: Patient Education on Ophthalmological Side Effects

Volume: 16 Number: 3 July 1, 2025
EN

Artificial Intelligence and Systemic Isotretinoin: Patient Education on Ophthalmological Side Effects

Abstract

Background/Purpose: Isotretinoin is frequently utilized in the treatment of skin disorders such as acne vulgaris and rosacea, with its associated side effects occurring relatively often. The most prevalent ophthalmological adverse effects include conjunctivitis, hordeolum, chalazion, blepharitis, and xerophthalmia. In light of the growing integration of artificial intelligence within healthcare, this study aims to evaluate the capability of ChatGPT to enhance patient education regarding these conditions. Materials and Methods: A questionnaire consisting of fifteen frequently asked questions concerning the ocular side effects of systemic isotretinoin was developed. Eight questions, selected by a dermatologist and a ophthalmologist, were posed to ChatGPT version 4.0. The responses were assessed using a four-point rating scale. Answers were independently categorized as "excellent," "satisfactory with minimal explanation required," "satisfactory with moderate explanation required," or "unsatisfactory." Results: ChatGPT provided accurate and informative responses to all eight questions presented. Six responses were rated as "excellent," while two were categorized as "satisfactory with minimal explanation required." Inter-rater reliability was assessed using Cohen's kappa analysis, resulting in a kappa value of 0.413 (95% confidence interval, 0.007 to 0.825). Conclusion: ChatGPT exhibited a significant capacity to effectively address patient inquiries related to the ophthalmological side effects of systemic isotretinoin. Following a review by dermatologists and ophthalmologists, it may serve as a valuable complementary tool for patient education.

Keywords

Thanks

OP.DR MURAT ERDAĞA MAKALEMİZE YAPTIGI KATKILAR ICIN TESEKKUR EDERIZ

References

  1. 1) Keleş H. Tıpta yapay zeka uygulamaları. Kırıkkale Üniversitesi Tıp Fakültesi, İç Hastalıkları A.D., Yahşihan, KIRIKKALE, TÜRKİYE.
  2. 2) Dave T, Athaluri SA, Singh S. ChatGPT in medicine: An overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell. 2023;6:1169595. Published 2023 May 4. doi:10.3389/frai.2023.1169595
  3. 3) ChatGPT-4 generates more accurate and complete responses to common patient questions about anterior cruciate ligament reconstruction than Google’s search engine.
  4. 4) Goktas P, Grzybowski A. Assessing the impact of ChatGPT in dermatology: A comprehensive rapid review. J Clin Med. 2024;13(19):5909. Published 2024 Oct 3. doi:10.3390/jcm13195909
  5. 5) Antaki F, Touma S, Milad D, El-Khoury J, Duval R. Evaluating the performance of ChatGPT in ophthalmology: An analysis of its successes and shortcomings. Ophthalmol Sci. 2023;3(4):100324. Published 2023 May 5. doi:10.1016/j.xops.2023.100324
  6. 6) Rajput I, Anjankar VP. Side effects of treating acne vulgaris with isotretinoin: A systematic review. Cureus. 2024;16(3)Published 2024 Mar 11. doi:10.7759/cureus.55946
  7. 7) Rocha M, Barnes F, Calderón J, et al. Acne treatment challenges - Recommendations of Latin American expert consensus. An Bras Dermatol. 2024;99(3):414-424. doi:10.1016/j.abd.2023.09.001
  8. 8) Ataseven A, Ugur Bilgin A. Effects of isotretinoin on the platelet counts and the mean platelet volume in patients with acne vulgaris. ScientificWorldJournal. 2014;2014:156464. doi:10.1155/2014/156464

Details

Primary Language

English

Subjects

Dermatology

Journal Section

Research Article

Early Pub Date

June 18, 2025

Publication Date

July 1, 2025

Submission Date

November 3, 2024

Acceptance Date

April 25, 2025

Published in Issue

Year 1970 Volume: 16 Number: 3

EndNote
Yigen İritaş S, İritaş İ (July 1, 2025) Artificial Intelligence and Systemic Isotretinoin: Patient Education on Ophthalmological Side Effects. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 16 3 336–343.